Abstract: Described are modified Noggin muteins, compositions comprising the muteins, and DNA or RNA sequences comprising coding (sense) or antisense sequences for the muteins.
Type:
Grant
Filed:
February 8, 2000
Date of Patent:
December 31, 2002
Assignees:
Regeneron Pharmaceuticals, Inc., Regents of the University of California
Inventors:
Aris Economides, Neil E. Stahl, Richard M. Harland